載入...
Establishment of a patient-derived intrahepatic cholangiocarcinoma xenograft model with KRAS mutation
BACKGROUND: Intrahepatic cholangiocarcinoma (ICC) is an aggressive, highly lethal tumors and lacks of effective chemo and targeted therapies. Cell lines and animal models, even partially reflecting tumor characteristics, have limits to study ICC biology and drug response. In this work, we created an...
Na minha lista:
| 發表在: | BMC Cancer |
|---|---|
| Main Authors: | , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
BioMed Central
2016
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4750214/ https://ncbi.nlm.nih.gov/pubmed/26868125 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-016-2136-1 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|